DRKS00016761已完成不适用
Quality of Life During Neoadjuvant Chemotherapy of Breast Cancer - QOLNEO
Gesellschaft für Klinische Forschung e.V.0 个研究点目标入组 54 人开始时间: 2019年5月6日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 54
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- Female
入选标准
- •1) Histologically confirmed UICC-stage I-III (without T0, Tis, T1mic) invasive adenocarcinoma of the breast
- •2) Planned neo-adjuvant chemotherapy according to the guidelines.
- •3) Age: 18 to 80 years
- •4) Gender: female
- •5) Performance status: ECOG 0-2
- •6) Legal competence
- •7) Voluntarily given written informed consent in advance for this observation.
排除标准
- •1) Pregnancy
- •2) Clinically significant concomitant condition critically influencing the ability of the patient to follow the requirements of the clinical observation.
- •3) Use of any investigational agent or participation in a clinical trial currently or during the last 4 weeks.
研究者
相似试验
尚未招募
不适用
Quality of life experience after neoadjuvant chemotherapy in HER2-positive breast cancer patients: a focus group studymamma carcinoma10006291breast cancerNL-OMON49288Antoni van Leeuwenhoek Ziekenhuis24
Unknown
不适用
Quality of Life in Advanced Gastric Cancer Patients Receiving Neoadjuvant ChemotherapyQOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant ChemotherapyNCT04408859Peking University Cancer Hospital & Institute290
招募中
不适用
Prospective study of neoadjuvant chemotherapy with FEC100x4 for BRCAness cases in triple negative breast cancerBreast cancerJPRN-UMIN000029433Tokyo medical university70
已完成
不适用
A Prospective Study of Neoadjuvant Chemotherapy with Nivolumab/Gemcitabine/Cisplatin in Muscle-Invasive or Locally-Advanced Urothelial Carcinoma of BladderKCT0003804Samsung Medical Center48
已完成
不适用
Prospective study of neoadjuvant chemotherapy for HER2 positive breast cancer.JPRN-UMIN000046338Sapporo Medical University24